MedTrace Logo

Concentration of MitoQ in Human Skeletal Muscle

NCT04098510 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2019-09-23

No results posted yet for this study

Summary

The purpose of this study is to determine mitoquinone mesylate concentration levels in skeletal muscle samples obtained after intake of an acute oral dose of MitoQ.

Conditions

  • Healthy

Interventions

DIETARY_SUPPLEMENT

MitoQ

Subjects ingest 8x20 mg MitoQ capsules

Sponsors & Collaborators

  • University of Copenhagen

    lead OTHER

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-09-08
Primary Completion
2020-09-30
Completion
2020-09-30

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04098510 on ClinicalTrials.gov